Table 3.
Deaths in placebo and azithromycin-treated clusters due to the top 10 causes using SmartVA
| SmartVA output cause | Number of deaths in placebo arm (%) | Number of deaths in azithromycin arm (%) | Number of deaths in both arms (%) | Percentage of deaths in placebo arm after redistribution | Percentage of deaths in azithromycin arm after redistribution | Percentage of deaths in both arms after redistribution |
|---|---|---|---|---|---|---|
| Malaria | 198 (33.2) | 184 (34.5) | 382 (33.8) | 39.1 | 40.9 | 40.0 |
| Undetermined | 133 (22.3) | 131 (24.5) | 264 (23.3) | 0.0 | 0.0 | 0.0 |
| AIDS | 71 (11.9) | 70 (13.1) | 141 (12.5) | 12.8 | 13.2 | 13.0 |
| Diarrhea/dysentery | 79 (13.2) | 56 (10.5) | 135 (11.9) | 16.1 | 13.0 | 14.6 |
| Other digestive diseases | 44 (7.4) | 50 (9.4) | 94 (8.3) | 7.6 | 9.5 | 8.5 |
| Pneumonia | 35 (5.9) | 20 (3.8) | 55 (4.9) | 10.3 | 10.0 | 10.1 |
| Fires | 8 (1.3) | 6 (1.1) | 14 (1.2) | 1.5 | 1.3 | 1.4 |
| Childhood cardiovascular diseases | 5 (0.8) | 4 (0.8) | 9 (0.8) | 1.1 | 1.1 | 1.1 |
| Meningitis | 5 (0.8) | 3 (0.6) | 8 (0.7) | 2.0 | 2.5 | 2.2 |
| Other infectious diseases | 6 (1.0) | 1 (0.2) | 7 (0.6) | 1.8 | 1.3 | 1.6 |
| Other | 13 (2.2) | 9 (1.7) | 22 (2.0) | 7.7 | 7.2 | 7.5 |
| Total | 597 (100) | 534 (100) | 1,131 (100) | 100 | 100 | 100 |